• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体γ的配体结合与共激活因子组装

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.

作者信息

Nolte R T, Wisely G B, Westin S, Cobb J E, Lambert M H, Kurokawa R, Rosenfeld M G, Willson T M, Glass C K, Milburn M V

机构信息

Department of Structural Chemistry, Glaxo Wellcome Research and Development, Research Triangle Park, North Carolina 27709, USA.

出版信息

Nature. 1998 Sep 10;395(6698):137-43. doi: 10.1038/25931.

DOI:10.1038/25931
PMID:9744270
Abstract

The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a ligand-dependent transcription factor that is important in adipocyte differentiation and glucose homeostasis and which depends on interactions with co-activators, including steroid receptor co-activating factor-1 (SRC-1). Here we present the X-ray crystal structure of the human apo-PPAR-gamma ligand-binding domain (LBD), at 2.2 A resolution; this structure reveals a large binding pocket, which may explain the diversity of ligands for PPAR-gamma. We also describe the ternary complex containing the PPAR-gamma LBD, the antidiabetic ligand rosiglitazone (BRL49653), and 88 amino acids of human SRC-1 at 2.3 A resolution. Glutamate and lysine residues that are highly conserved in LBDs of nuclear receptors form a 'charge clamp' that contacts backbone atoms of the LXXLL helices of SRC-1. These results, together with the observation that two consecutive LXXLL motifs of SRC-1 make identical contacts with both subunits of a PPAR-gamma homodimer, suggest a general mechanism for the assembly of nuclear receptors with co-activators.

摘要

过氧化物酶体增殖物激活受体γ(PPAR-γ)是一种依赖配体的转录因子,在脂肪细胞分化和葡萄糖稳态中起重要作用,它依赖于与包括类固醇受体共激活因子-1(SRC-1)在内的共激活因子相互作用。在此,我们展示了分辨率为2.2埃的人无配体PPAR-γ配体结合域(LBD)的X射线晶体结构;该结构揭示了一个大的结合口袋,这可能解释了PPAR-γ配体的多样性。我们还描述了分辨率为2.3埃的包含PPAR-γ LBD、抗糖尿病配体罗格列酮(BRL49653)和人SRC-1的88个氨基酸的三元复合物。在核受体LBD中高度保守的谷氨酸和赖氨酸残基形成一个“电荷钳”,与SRC-1的LXXLL螺旋的主链原子接触。这些结果,连同观察到SRC-1的两个连续LXXLL基序与PPAR-γ同二聚体的两个亚基进行相同接触,提示了核受体与共激活因子组装的一般机制。

相似文献

1
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.过氧化物酶体增殖物激活受体γ的配体结合与共激活因子组装
Nature. 1998 Sep 10;395(6698):137-43. doi: 10.1038/25931.
2
Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.控制核受体异二聚体与共激活因子组装的相互作用。
Nature. 1998 Sep 10;395(6698):199-202. doi: 10.1038/26040.
3
Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation.通过核磁共振光谱监测配体诱导的PPARγ稳定化:对核受体激活的影响。
J Mol Biol. 2000 Apr 28;298(2):187-94. doi: 10.1006/jmbi.2000.3636.
4
Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.雌激素相关受体α配体结合域及其与配体和共激活因子复合物结构的小角X射线散射研究
J Phys Chem B. 2008 Aug 14;112(32):9603-12. doi: 10.1021/jp800120r. Epub 2008 Jul 23.
5
Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.过氧化物酶体增殖物激活受体配体对共抑制因子亲和力的亚型特异性影响。
Biochemistry. 2003 Aug 12;42(31):9278-87. doi: 10.1021/bi034472c.
6
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.PPARα拮抗剂介导核共抑制因子募集的结构基础
Nature. 2002 Feb 14;415(6873):813-7. doi: 10.1038/415813a.
7
Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.人源LRH-1 DBD-DNA复合物的晶体结构揭示受体活性需要Ftz-F1结构域定位。
J Mol Biol. 2005 Dec 16;354(5):1091-102. doi: 10.1016/j.jmb.2005.10.009. Epub 2005 Oct 27.
8
Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain.
Anal Biochem. 1998 Mar 15;257(2):112-9. doi: 10.1006/abio.1997.2557.
9
Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.过氧化物酶体增殖物激活受体γ共激活因子新界面的合理发现:2型糖尿病受损的理论意义
Proteins. 2005 Feb 1;58(2):418-25. doi: 10.1002/prot.20266.
10
RARbeta ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis.与SRC-1共激活因子肽结合的RARβ配体结合域:纯化、结晶及初步X射线衍射分析
Acta Crystallogr D Biol Crystallogr. 2004 Nov;60(Pt 11):2048-50. doi: 10.1107/S0907444904021201. Epub 2004 Oct 20.

引用本文的文献

1
Imaging Ligand-Driven PPAR Activities Using Single-Chain Bioluminescent Probes.使用单链生物发光探针成像配体驱动的过氧化物酶体增殖物激活受体(PPAR)活性
ACS Omega. 2025 Jul 24;10(30):33850-33861. doi: 10.1021/acsomega.5c04665. eCollection 2025 Aug 5.
2
PPGBioPred: a webserver for predicting the bioactivity of compounds against PPARγ involved in the negative regulation of the Wnt/β-catenin signaling pathway.PPGBioPred:一个用于预测化合物对参与Wnt/β-连环蛋白信号通路负调控的PPARγ生物活性的网络服务器。
Mol Divers. 2025 Jul 22. doi: 10.1007/s11030-025-11297-1.
3
Predicting peroxisome proliferator-activated receptor gamma potency of small molecules: a synergistic consensus model and deep learning binding affinity approach powered by Enalos Cloud Platform.
预测小分子的过氧化物酶体增殖物激活受体γ活性:一种由Enalos云平台驱动的协同共识模型和深度学习结合亲和力方法
Mol Divers. 2025 Jun 14. doi: 10.1007/s11030-025-11230-6.
4
Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator.新型喹啉噻唑烷二酮杂合物作为潜在抗糖尿病PPARγ调节剂的设计与合成
Sci Rep. 2025 Jun 1;15(1):19207. doi: 10.1038/s41598-025-03387-9.
5
Discovery of a novel binding pocket in PPARγ for partial agonists: structure-based virtual screening identifies ginsenoside Rg5 as a partial agonist promoting beige adipogenesis.发现过氧化物酶体增殖物激活受体γ(PPARγ)中一个用于部分激动剂的新型结合口袋:基于结构的虚拟筛选鉴定人参皂苷Rg5为促进米色脂肪生成的部分激动剂。
Front Chem. 2025 May 8;13:1579445. doi: 10.3389/fchem.2025.1579445. eCollection 2025.
6
Expression of Peroxisome Proliferator-Activated Receptor γ in Human Colorectal Carcinoma and Its Correlation with Clinicopathological Characteristics.过氧化物酶体增殖物激活受体γ在人结直肠癌中的表达及其与临床病理特征的相关性
Indian J Surg Oncol. 2025 Apr;16(2):685-690. doi: 10.1007/s13193-024-02122-6. Epub 2024 Nov 7.
7
From Apo to Ligand-Bound: Unraveling PPARγ-LBD Conformational Shifts via Advanced Molecular Dynamics.从脱辅基状态到配体结合状态:通过高级分子动力学解析PPARγ配体结合域的构象转变
ACS Omega. 2025 Feb 17;10(13):13303-13318. doi: 10.1021/acsomega.4c11128. eCollection 2025 Apr 8.
8
Structure-Based Design and Optimization Lead to the Identification of a Novel Potent sEH Inhibitor with PPARγ Partial Agonist Activity against Inflammatory and Metabolic-Related Diseases.基于结构的设计与优化促成了一种新型强效可溶性环氧化物水解酶(sEH)抑制剂的发现,该抑制剂具有过氧化物酶体增殖物激活受体γ(PPARγ)部分激动活性,可用于治疗炎症和代谢相关疾病。
J Med Chem. 2025 Apr 24;68(8):8729-8767. doi: 10.1021/acs.jmedchem.5c00402. Epub 2025 Apr 4.
9
Molecular interactions between piperine and peroxisome proliferator-activated receptor gamma ligand-binding domain revealed using co-crystallization studies.利用共结晶研究揭示胡椒碱与过氧化物酶体增殖物激活受体γ配体结合域之间的分子相互作用。
Acta Crystallogr F Struct Biol Commun. 2025 May 1;81(Pt 5):201-206. doi: 10.1107/S2053230X25002377. Epub 2025 Apr 2.
10
Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.鉴定前列腺素还原酶2(PTGR2)抑制剂作为糖尿病和肥胖症的一种新治疗策略。
EMBO Mol Med. 2025 May;17(5):938-966. doi: 10.1038/s44321-025-00216-4. Epub 2025 Mar 21.